TETRASODIUM 4-((4',5-DISULFO(1,1'-BIPHENYL)-2-YL)HYDRAZONO)-4,5-DIHYDRO-5-OXO-1-(4-SULFOPHENYL)-1H-PYRAZOLE-3-CARBOXYLATE
UNII G314C5X035
Substance Identification & Data
This profile provides standardized clinical and technical data for Tetrasodium 4-((4',5-disulfo(1,1'-biphenyl)-2-yl)hydrazono)-4,5-dihydro-5-oxo-1-(4-sulfophenyl)-1h-pyrazole-3-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) G314C5X035.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 104728-61-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H12N4O12S3.4Na UHGKPOZWZNEDHC-HHFSKNRISA-J Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Tetrasodium 4-((4',5-disulfo(1,1'-biphenyl)-2-yl)hydrazono)-4,5-dihydro-5-oxo-1-(4-sulfophenyl)-1h-pyrazole-3-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.